OTC Markets OTCPK - Delayed Quote USD

BioStem Technologies, Inc. (BSEM)

12.00
-0.14
(-1.15%)
At close: 3:59:50 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
16,685.41
16,685.41
6,875.20
4,340.84
2,521.64
Cost of Revenue
1,261.75
1,261.75
881.75
1,474.77
1,269.78
Gross Profit
15,423.66
15,423.66
5,993.45
2,866.07
1,251.86
Operating Expense
22,582.42
22,582.42
10,675
4,471.77
3,094.13
Operating Income
-7,158.77
-7,158.77
-4,681.55
-1,605.71
-1,842.26
Net Non Operating Interest Income Expense
-700.33
-700.33
-468.15
-525.88
-526.97
Other Income Expense
-3.69
-3.69
-2,082.10
719.81
--
Pretax Income
-7,862.78
-7,862.78
-7,231.80
-1,411.78
-2,369.23
Tax Provision
0
0
0
--
0
Net Income Common Stockholders
-7,862.78
-7,862.78
-7,192.95
-1,445.38
-2,389.23
Diluted NI Available to Com Stockholders
-7,862.78
-7,862.78
-7,192.95
-1,445.38
-2,389.23
Basic EPS
-0.57
--
-0.63
-0.12
-0.26
Diluted EPS
-0.57
--
-0.63
-0.12
-0.26
Basic Average Shares
13,707.08
--
11,405
11,685.29
9,177.40
Diluted Average Shares
13,707.08
--
11,405
11,685.29
9,177.40
Total Operating Income as Reported
-7,158.77
-7,158.77
-4,681.55
-1,605.71
-1,842.26
Total Expenses
23,844.17
23,844.17
11,556.75
5,946.54
4,363.90
Net Income from Continuing & Discontinued Operation
-7,862.78
-7,862.78
-7,192.95
-1,445.38
-2,389.23
Normalized Income
-7,862.78
-7,862.78
-5,109.75
-2,134.74
-2,389.23
Interest Income
--
--
--
--
3.93
Interest Expense
700.33
700.33
468.15
525.88
530.90
Net Interest Income
-700.33
-700.33
-468.15
-525.88
-526.97
EBIT
-7,162.46
-7,162.46
-6,763.64
-885.90
-1,838.33
EBITDA
-6,933.43
-6,933.43
-6,520.23
-602
-1,594.86
Reconciled Cost of Revenue
1,261.74
1,261.74
902.71
1,474.88
1,269.78
Reconciled Depreciation
229.02
229.02
222.47
283.79
243.47
Net Income from Continuing Operation Net Minority Interest
-7,862.78
-7,862.78
-7,192.95
-1,445.38
-2,389.23
Total Unusual Items Excluding Goodwill
0
0
-2,083.20
689.36
0
Total Unusual Items
0
0
-2,083.20
689.36
0
Normalized EBITDA
-6,933.43
-6,933.43
-4,437.03
-1,291.36
-1,594.86
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2020 - 3/17/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

GMAB Genmab A/S
19.65
+2.99%
 
SILO Silo Pharma, Inc.
0.5199
-37.81%
 
VRCA Verrica Pharmaceuticals Inc.
0.6418
+19.90%
 
MAIA MAIA Biotechnology, Inc.
1.7700
+0.57%
 
MDCLF MedinCell S.A.
6.98
0.00%
 
NNVC NanoViricides, Inc.
1.3100
+3.97%
 
CLSD Clearside Biomedical, Inc.
0.8645
+1.23%
 
SGMT Sagimet Biosciences Inc.
3.3100
+6.77%
 
RGNX REGENXBIO Inc.
8.64
+3.72%
 
KRYS Krystal Biotech, Inc.
130.33
-0.81%